IMASONIC SAS

Their core work

IMASONIC is a French SME that designs and manufactures custom ultrasound transducers and phased array probes for medical imaging and industrial applications. Within EU research projects, they contribute specialized hardware — ultrasound and photoacoustic sensor components — enabling advanced imaging systems for biomedical diagnostics. Their projects span breast cancer screening (PAMMOTH), intestinal imaging (EUPHORIA), and bio-photonic imaging (FBI), consistently positioning them as the transducer technology supplier in multi-partner medical imaging consortia.

What they specialise in

How they've shifted over time

IMASONIC entered H2020 in 2016 through the FBI project, contributing to fundamental research in bio-photonic imaging under a Marie Curie training network. By 2017-2019, their focus shifted decisively toward applied clinical diagnostics — first breast cancer screening (PAMMOTH) and then intestinal imaging (EUPHORIA), both combining photoacoustic and ultrasound modalities. The trajectory shows a clear move from basic research participation toward closer-to-market medical device development.

IMASONIC is moving toward clinical-grade photoacoustic/ultrasound imaging hardware, making them a strong partner for medical device development projects targeting regulatory approval.

How they like to work

IMASONIC never coordinates — they join as a specialist component supplier in medium-to-large consortia. With 24 unique partners across 9 countries from just 3 projects, they operate in broad European networks led by research hospitals and universities. Their role is consistent: they bring the hardware expertise while academic and clinical partners handle algorithms, clinical validation, and system integration.

Collaborated with 24 partners across 9 countries in just 3 projects, indicating involvement in sizeable research consortia. Their network is firmly European, likely centered on medical imaging research groups in Western Europe.

What sets them apart

IMASONIC occupies a rare niche as an SME that can design and manufacture custom ultrasound transducers tailored to research specifications — something most academic labs cannot do in-house. For any consortium developing a new imaging modality that requires bespoke ultrasound or photoacoustic probes, IMASONIC is one of very few European companies that can deliver research-grade custom hardware. Their repeat involvement across multiple imaging projects confirms they are a trusted, proven supplier in this space.

Highlights from their portfolio

• PAMMOTH
  Largest funding (EUR 760,000) — developing a combined photoacoustic/ultrasound mammography system to improve breast cancer screening beyond conventional methods.
• EUPHORIA
  Most recent project (2019-2022), extending IMASONIC's photoacoustic expertise into gastrointestinal diagnostics, signaling expansion into new clinical domains.